Patent details
92349 Product Name: "Lomitapide et toutes ses formes thérapeutiquement équivalentes telles que protégées par le brevet de base"
Basic Information
- Publication number:
- 92349
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP057248874
- Legal Status:
- Active
- Application number:
- 92349
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/13/851/001-002-003 LOJUXTA - lomitapide
- Marketing Authorization Type:
- Marketing Authorization Date:
- 05/08/2013
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 06/01/2014
- First Marketing Authorization date:
- 05/08/2013
- Grant date:
- 02/11/2015
- Activation date:
- 07/03/2025
- Publication date:
- 02/11/2015
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 05/08/2028
- SPC Extension Expiration:
- 05/08/2028
- Rejection date:
- Withdrawal date:
Owner
- From:
- 06/01/2014
- Name:
- The Trustees of The University of Pennsylvania
- Address:
- 3160 Chestnut Street, Suite 200, Philadelphia, Pennsylvania 19104-6283, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 06/01/2014
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
- Name:
- RADER Daniel, J.
- Address:
- United States (US)
Publication
Bulletin
- Bulletin Heading:
- SPC3
- Bulletin edition number:
- 2025/05
- Publication date:
- 07/04/2025
- Description:
- Section E : Supplementary Protection certificates entered into force – IA publication
Annual Fees
- Annual Fee Due Date:
- 31/03/2027
- Annual Fee Number:
- 23
- Annual Fee Amount:
- 430 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 19/03/2026
- Last Annual Fee Paid Number:
- 22
- Last Annual Fee Paid Amount:
- 420 Euro
- Payer:
- DENNEMEYER & CO
| Filing date | Document type | Number of pages |
|---|